Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.
about
Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than othersEffects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials.The eicosanoid cascade: possible role in gliomas and meningiomas.Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trialsEffects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
P2860
Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Outcome trials of COX-2 select ...... ion does not promise benefits.
@ast
Outcome trials of COX-2 select ...... ion does not promise benefits.
@en
type
label
Outcome trials of COX-2 select ...... ion does not promise benefits.
@ast
Outcome trials of COX-2 select ...... ion does not promise benefits.
@en
prefLabel
Outcome trials of COX-2 select ...... ion does not promise benefits.
@ast
Outcome trials of COX-2 select ...... ion does not promise benefits.
@en
P2093
P2860
P1476
Outcome trials of COX-2 select ...... tion does not promise benefits
@en
P2093
Jorge Gomez Cerezo
Juan J Vázquez Rodríguez
Rubin Lubomirov Hristov
P2860
P2888
P304
P356
10.1007/S00228-003-0579-1
P577
2003-04-16T00:00:00Z